Failure to disclose source and composition of active agent topical chlorhexidine in peer-reviewed publications - 03/08/18
Aliaa Ismail, MBBCh, Department of Dermatology, Alexandria University, and Egypt and Northwestern University, USA; Erin Budris, University of Illinois; Mackenzie Allen, Department of Dermatology, Northwestern University Feinberg School of Medicine; Amanda Maisel, BS, Department of Dermatology, Northwestern University Feinberg School of Medicine; Rema Zebda, MD, Department of Dermatology, Northwestern University Feinberg School of Medicine; Krishna Patel, MD, Department of Dermatology, Northwestern University Feinberg School of Medicine; Kara Ramsey, BS, Department of Dermatology, Northwestern University Feinberg School of Medicine; Rame Yousif, BS, Department of Dermatology, Northwestern University Feinberg School of Medicine; William A. Budris, BPharm, Pharmacy, Drug Information Center Northwestern Memorial Hospital; Dennis P. West, PhD, Department of Dermatology, Northwestern University Feinberg School of Medicine
Le texte complet de cet article est disponible en PDF.| Commercial support: None identified. |
Vol 79 - N° 3S1
P. AB141 - septembre 2018 Retour au numéro
Article précédent
- Factors affecting dermatologists’ decision to use a 31-gene expression profiling test to assess metastatic risk for melanoma patients
- Familial aplasia cutis congenita: A case report
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?